NCT00678483 - Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients | Biotech Hunter

Enrollment

331

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions

ObesityWeight Loss

Interventions

DRUG

rimonabant (SR141716)

once daily

Trial Locations (5)

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Helsinki

Sanofi- Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Bucharest